"Fluorocarbons" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Liquid perfluorinated carbon compounds which may or may not contain a hetero atom such as nitrogen, oxygen or sulfur, but do not contain another halogen or hydrogen atom. This concept includes fluorocarbon emulsions and fluorocarbon blood substitutes.
| Descriptor ID |
D005466
|
| MeSH Number(s) |
D02.455.526.510.435
|
| Concept/Terms |
Fluorinated Telomer Alcohols- Fluorinated Telomer Alcohols
- Alcohols, Fluorinated Telomer
- Telomer Alcohols, Fluorinated
- Polyfluorinated Telomer Alcohols
- Alcohols, Polyfluorinated Telomer
- Telomer Alcohols, Polyfluorinated
- Fluoro-Telomer Alcohols
- Alcohols, Fluoro-Telomer
- Fluoro Telomer Alcohols
|
Below are MeSH descriptors whose meaning is more general than "Fluorocarbons".
Below are MeSH descriptors whose meaning is more specific than "Fluorocarbons".
This graph shows the total number of publications written about "Fluorocarbons" by people in this website by year, and whether "Fluorocarbons" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 0 | 3 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 2 | 2 | 4 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 1 | 4 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 2 | 1 | 3 |
| 2014 | 1 | 0 | 1 |
| 2016 | 1 | 2 | 3 |
| 2019 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fluorocarbons" by people in Profiles.
-
Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice. J Am Soc Echocardiogr. 2024 Mar; 37(3):276-284.e3.
-
Method for estimation of apoptotic cell fraction of cytotherapy using in vivo fluorine-19 magnetic resonance: pilot study in a patient with head and neck carcinoma receiving tumor-infiltrating lymphocytes labeled with perfluorocarbon nanoemulsion. J Immunother Cancer. 2023 06; 11(6).
-
Contrast-enhanced echocardiographic measurement of longitudinal strain: accuracy and its relationship with image quality. Int J Cardiovasc Imaging. 2020 Mar; 36(3):431-439.
-
Differentiating spontaneous echo contrast, sludge, and thrombus in the left atrial appendage: Can ultrasound enhancing agents help? Echocardiography. 2019 07; 36(7):1413-1417.
-
In vitro thrombolytic efficacy of echogenic liposomes loaded with tissue plasminogen activator and octafluoropropane gas. Phys Med Biol. 2017 01 21; 62(2):517-538.
-
Efficacy of histotripsy combined with rt-PA in vitro. Phys Med Biol. 2016 07 21; 61(14):5253-74.
-
A Simple Pharmacokinetic Model of Prenatal and Postnatal Exposure to Perfluoroalkyl Substances (PFASs). Environ Sci Technol. 2016 Jan 19; 50(2):978-86.
-
Cavitation thresholds of contrast agents in an in vitro human clot model exposed to 120-kHz ultrasound. J Acoust Soc Am. 2014 Feb; 135(2):646-53.
-
Broadband attenuation measurements of phospholipid-shelled ultrasound contrast agents. Ultrasound Med Biol. 2014 Feb; 40(2):410-21.
-
Effect of Optison on pulmonary artery systolic pressure and pulmonary vascular resistance. Am J Cardiol. 2013 Nov 15; 112(10):1657-61.